CUSIP: 09062W204
Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,953,549
-
Total 13F shares
-
14,927,170
-
Share change
-
+2,711,814
-
Total reported value
-
$244,144,153
-
Put/Call ratio
-
0%
-
Price per share
-
$16.35
-
Number of holders
-
82
-
Value change
-
+$49,280,131
-
Number of buys
-
47
-
Number of sells
-
22
Quarterly Holders Quick Answers
What is CUSIP 09062W204?
CUSIP 09062W204 identifies BLFS - BIOLIFE SOLUTIONS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2020
-
Previous quarter:
Q1 2020
Recent filing periods for CUSIP 09062W204:
Institutional Holders of BIOLIFE SOLUTIONS INC - Common Stock (BLFS) as of Q2 2020
As of 30 Jun 2020,
BIOLIFE SOLUTIONS INC - Common Stock (BLFS) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,927,170 shares.
The largest 10 holders included
Casdin Capital, LLC, SENTINEL PENSION ADVISORS INC, AMERIPRISE FINANCIAL INC, VANGUARD GROUP INC, Park West Asset Management LLC, ROYCE & ASSOCIATES LP, Russell Investments Group, Ltd., BlackRock Inc., Ranger Investment Management, L.P., and Tarsadia Capital, LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.